Three separate jab candidates are being developed to target the Bundibugyo strain of Ebola, which has been linked by health bureaucrats to nearly 250 deaths and more than 1,000 suspected cases in the Democratic Republic of Congo, with confirmed cases also reported in Uganda.
The vaccines are being developed by the International AIDS Vaccine Initiative, University of Oxford and Moderna, with funding from the Coalition for Epidemic Preparedness Innovations.
Existing vaccines for the more common Zaire strain are not effective against the strain present in the Bundibugyo outbreak.
The Oxford candidate could enter clinical trials within two to three months, while IAVI estimates its vaccine could be ready for trials within seven to nine months. All three vaccines use different technologies but are designed to train the immune system to recognise and respond to the Bundibugyo virus.
Image credit: Getty Images
I bet New Zealanders are wetting beds in excitement to take the new Ebola vaccine. Super Saturday 2.0.
Breaking News Breaking News:
A new highly infectious bundibugyo variant has been identified.
The new emerging variant is bundibergyo and is especially toxic to males.
Exposure to Bundibergyo cause males to exhibit female characteristics and female behaviours
Once infected men talk nonsense, become emotional and can no longer drive
Its true, its true – I wouldn’t lie about serious things like this.
The government should think very carefully about investing in so call vaccine medications.
Most of the country isn’t going to take it.
Political parties have been known to crumble into dust for such foolish behaviour.
Seriously? It has become so obvious that virus development is the new gold mining. The vaccine industry is a rort.